December 1, 2016 09:15 AM EST
News Briefing

Mag­ic mush­rooms treat de­pres­sion, anx­i­ety felt by can­cer pa­tients; Mer­ck wins a speedy re­view sched­ule for lat­est Keytru­da ini­tia­tive

Shehla Shakoor

Managing Director

Yes­ter­day’s sto­ry about the po­ten­tial use of an il­lic­it drug for a neu­ropsy­chi­atric con­di­tion fo­cused on MD­MA (ec­sta­sy) for post-trau­mat­ic stress dis­or­der. To­day we …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times